Cromos Pharma, where the patients are

R&D Trends

Report: Venture capital in life sciences sector trailing other industries

Wednesday, February 19, 2014 01:14 PM

Venture capital funding for the life sciences sector, which includes biotechnology and medical devices, declined in 2013 by 1% in dollars invested and 3% in number of deals, compared to 2012, according to a new PwC U.S. report, Medtech Slowdown, which includes data from the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters

More... »

CRF Health eCOA webinar series

Soligenix recieves $300,000 NIAID SBIR grant award for Melioidosis

Friday, February 14, 2014 01:46 PM

Soligenix, a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), to support further preclinical development of SGX943 as a treatment for melioidosis. The award will provide Soligenix with approximately $300,000 over one year to conduct the studies in collaboration with Tulane University.

More... »

Medimmune, UC San Francisco collaborate

Friday, February 14, 2014 01:40 PM

MedImmune, the global biologics R&D arm of AstraZeneca, has entered a three-year collaboration with the Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF).  The collaboration will focus on CTSI's Catalyst Awards program, which solicits applications from University scientists who wish to move their translational research beyond the bench and into product development.

More... »

Spectrum Health, Van Andel Research Institute launch cardiovascular research program

Thursday, February 13, 2014 02:54 PM

Van Andel Research Institute, an independent research and educational organization, and Spectrum Health, a nonprofit health system, have collaborated to bring cardiovascular researcher and cardiologist Stefan Jovinge M.D., Ph.D., to Grand Rapids, Mich.

More... »

Aurigene, Pierre Fabre Pharmaceuticals ink cancer licensing agreement

Thursday, February 13, 2014 02:17 PM

Pierre Fabre, a French pharmaceutical company, and Aurigene, a biotech company based in India, have entered into a collaborative license, development and commercialization agreement granting Pierre Fabre global worldwide rights (excluding India) to a new immune checkpoint modulator, AUNP-12.

More... »

Report: global pharma growth linked to expansion in emerging markets, best practices

Wednesday, February 12, 2014 01:46 PM

China is expected to generate 27% of the world's pharmaceutical growth from 2011 to 2015. The world's largest country by population, China also is the key to the economic engine of the emerging markets, according to a study from Best Practices, a research, consulting and publishing firm.

More... »

Debiopharm Group to acquire Affinium's Antibiotic clinical assets and platform

Wednesday, February 12, 2014 01:41 PM

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs for unmet medical and companion diagnostics, will acquire Affinium Pharmaceuticals’ clinical and preclinical assets, as well as its technology platform.

More... »

Medical Research Council awards $52.9 million to improve data research

Wednesday, February 12, 2014 01:34 PM

The Medical Research Council (MRC) has made an investment of $52.9 million to improve capability, capacity and capital infrastructure in medical bioinformatics.

More... »

Critical Path Institute receives grant for tuberculosis treatments

Wednesday, February 12, 2014 01:31 PM

The Critical Path Institute, an independent nonprofit that catalyzes innovative ideas to accelerate the speed of drug and medical product development, has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop quantitative mathematical models to optimize the design of clinical trials and tackle challenges facing the development of effective tuberculosis (TB) treatments.  

More... »

DaVita Clinical Research, Pyxant Labs to collaborate

Wednesday, February 12, 2014 01:23 PM

Pyxant Labs has partnered with DaVita Clinical Research (DCR), a specialty CRO with services for both drug and device development, to provide bioanalytical laboratory services for DCR's early clinical trials.

More... »

CenterWatch Drugs in Clinical Trials



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs